Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Evogene Ltd. - Ordinary Shares
(NQ:
EVGN
)
1.020
-0.030 (-2.86%)
Streaming Delayed Price
Updated: 9:41 AM EST, Jan 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Evogene Ltd. - Ordinary Shares
< Previous
1
2
3
4
Next >
Recap: Evogene Q3 Earnings
↗
November 15, 2023
Via
Benzinga
A Preview Of Evogene's Earnings
↗
November 14, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 2, 2023
↗
October 02, 2023
Via
Benzinga
Why Evogene Shares Are Moving
↗
September 21, 2023
Evogene Ltd (NASDAQ: EVGN) shares are trading lower by 5.9% to $0.63 Thursday morning after the company received a letter from the Nasdaq indicating that the company is not in compliance with the...
Via
Benzinga
Lake Street Maintains Buy Rating for Evogene: Here's What You Need To Know
↗
August 18, 2023
Via
Benzinga
Earnings Outlook For Evogene
↗
August 16, 2023
Via
Benzinga
Evogene's Casterra Gets $2.2M Orders To Supply Castor Seeds
↗
July 03, 2023
Evogene Ltd. (NASDAQ: EVGN) said its unit Casterra Ag Ltd.
Via
Benzinga
TalkMarkets Announces Company Spotlight Featuring Evogene
↗
June 22, 2023
TalkMarkets.com announces a company spotlight series featuring Evogene (NASDAQ: EVGN), an agri-tech and bio-tech company with a computational predictive biological platform technology.
Via
Talk Markets
Israeli Cannabis Co. Reports Solid Q2 Performance, Nearing Growth Targets
↗
August 17, 2023
Cannabis company Evogene Ltd.
Via
Benzinga
Topics
Cannabis
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
July 17, 2023
Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived...
Via
Benzinga
Why Evogene Stock Is Tanking Today
↗
July 17, 2023
Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) shares were trading 20% lower at $1.12 per share at the time of writing Monday morning.
Via
Benzinga
Evogene: Q1 Earnings Insights
↗
May 18, 2023
Via
Benzinga
Evogene's Earnings Outlook
↗
May 17, 2023
Via
Benzinga
Evogene 2022 Revenue Grows 80% To 1.7M
↗
March 09, 2023
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) 2022 revenue was $1.7 million, an increase of 80% compared to $930,000 in 2021. Q4 Financial Highlights
Via
Benzinga
Evogene's Earnings Outlook
↗
March 08, 2023
Via
Benzinga
Why Aehr Test Systems Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
↗
July 14, 2023
Gainers Ainos, Inc. (NASDAQ: AIMD) shares surged 108.2% to $1.52 in pre-market trading after gaining around 7% on Thursday.
Via
Benzinga
TalkMarkets Announces Company Spotlight Featuring Evogene
June 22, 2023
TalkMarkets.com announces a company spotlight series featuring Evogene (NASDAQ: EVGN), an agri-tech (agricultural technology) and bio-tech company with a computational predictive biological platform...
Via
TheNewswire.com
TalkMarkets Announces Company Spotlight Featuring Evogene
June 22, 2023
TalkMarkets.com announces a company spotlight series featuring Evogene (NASDAQ: EVGN), an agri-tech and bio-tech company with a computational predictive biological platform technology.
Via
News Direct
Evogene - A Company With Valuable Assets Trading At Zero Enterprise Value
↗
June 22, 2023
From a sum-of-parts perspective, Evogene is likely worth many multiples of its market valuation today, even without ascribing any value to Evogene’s technology.
Via
Talk Markets
Why ToughBuilt Industries Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
June 21, 2023
Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 209.5% to $2.29 after the company signed a Letter of Intention with UAE-Based e-script medicine management company Pharmak...
Via
Benzinga
Why Evogene (EVGN) Stock Is Trading Higher
↗
June 21, 2023
Evogene Ltd (NASDAQ: EVGN) shares are trading higher by 13.72% to $0.83 Wednesday morning after the company announced its subsidiary, Casterra, signed a framework agreement with an oil & gas company to...
Via
Benzinga
Tryp Submits IND Application To FDA For Clinical Trial Of Psilocybin-Assisted Psychotherapy In Patients With IBS
↗
May 24, 2023
Tryp Therapeutics, Inc. (OTCQB: TRYPF) (CSE:TRYP) has submitted an Investigational New Drug application to the U.S.
Via
Benzinga
Evogene Q1 Revenue Grows 170% YoY, Here Are The Details
↗
May 18, 2023
Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) released its financial results for the first quarter period ending March 31, 2023, revealing revenues of $641,000, an increase of 170% compared to $237,000 in...
Via
Benzinga
Earnings Scheduled For May 18, 2023
↗
May 18, 2023
Companies Reporting Before The Bell • Lightspeed Commerce (NYSE:LSPD) is projected to report quarterly loss at $0.04 per share on revenue of $248.01 million.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2023
↗
May 02, 2023
Via
Benzinga
Looking To Invest In Artificial Intelligence? Consider Evogene And Its Five Subsidiaries
↗
April 27, 2023
Evogene employs an artificial intelligence platform for decoding plant phenotypes and microbial genomes. Consider its' research agenda, applications, and at-the-market products. The set-up may present...
Via
Talk Markets
Evogene Offers An Excellent Risk/Reward Ratio
↗
March 21, 2023
We think the company’s main CPB computational engine has the potential to be an extraordinary value creation engine. Investors only need one of the company's subsidiaries to succeed, to de-risk their...
Via
Talk Markets
Canonic Launches Six Second-Generation Cannabis Products With Higher THC And Rich Terpene Profiles
↗
February 21, 2023
Canonic Ltd., a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) launched six second-generation hybrid cannabis products in Israel.
Via
Benzinga
Evogene Q3 Revenue Grows 208% YoY, Here Are The Details
↗
November 17, 2022
Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) Q3 2022 revenues were $466,000, a 208% increase in comparison to $151,000 in the same period of the previous year and were primarily due to revenues recognized...
Via
Benzinga
Earnings Scheduled For November 17, 2022
↗
November 17, 2022
Companies Reporting Before The Bell • Jumia Technologies (NYSE:JMIA) is expected to report quarterly loss at $0.76 per share on revenue of $57.32 million.
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
